Opthea Limited
OPT
Cena:
Valuace
100
Růst
33
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
OPTHEA PROVIDES CORPORATE UPDATE
18-08-2025
SUCCESSFUL DFA SETTLEMENT REACHED COMPANY WITH CASH AND CASH EQUIVALENTS OF APPROXIMATELY USD20M DR ...
Více zde
OPTHEA ANNOUNCES DECISION TO DISCONTINUE WET AMD TRIALS
31-03-2025
SHORE PHASE 3 TOPLINE RESULTS ACCELERATED; TRIAL DID NOT MEET PRIMARY ENDPOINT OF MEAN CHANGE IN BCV...
Více zde
OPTHEA ANNOUNCES COAST PHASE 3 TRIAL TOPLINE RESULTS
24-03-2025
COAST PHASE 3 TRIAL FAILED TO MEET PRIMARY ENDPOINT OF MEAN CHANGE IN BCVA FROM BASELINE TO WEEK 52 ...
Více zde
OPTHEA ANNOUNCES PHASE 2B WET AMD PUBLICATION
03-03-2025
BASELINE ANGIOGRAPHIC LESION CHARACTERISTICS PREDICTIVE OF CLINICAL RESPONSE PUBLISHED IN PEER-REVI...
Více zde
OPTHEA TO PRESENT AT OPPENHEIMER HEALTHCARE CONFERENCE
07-02-2025
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., FEB. 07, 2025 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NASD...
Více zde
OPTHEA WET AMD DATA FEATURED AT MACULA SOCIETY MEETING
06-02-2025
MELBOURNE, AUSTRALIA, AND PRINCETON, N.J., FEB. 06, 2025 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NAS...
Více zde
OPTHEA TO HOST INVESTOR DAYS IN NEW YORK AND AUSTRALIA
08-01-2025
UPDATES ON COMMERCIAL INSIGHTS AND READINESS PLANS FOR SOZINIBERCEPT IN WET AMD OPTHEA MANAGEMENT TO...
Více zde
OPTHEA TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
19-12-2024
BUSINESS UPDATE TO INCLUDE MASKED PHASE 3 PATIENT DEMOGRAPHICS AND BASELINE CHARACTERISTICS PRESENTA...
Více zde
OPTHEA'S WET AMD PROGRAM TO BE FEATURED AT FLORETINA 2024
26-11-2024
MELBOURNE, AUSTRALIA, AND PRINCETON, N.J., NOV. 26, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NAS...
Více zde
OPTHEA APPOINTS KATHY CONNELL TO BOARD OF DIRECTORS
15-11-2024
MS. CONNELL IS A COMMERCIAL EXECUTIVE WITH BUSINESS DEVELOPMENT EXPERTISE APPOINTMENT TAKES PLACE AS...
Více zde
OPTHEA WET AMD PROGRAM TO BE PRESENTED AT INNOVATE RETINA
10-10-2024
MELBOURNE, AUSTRALIA, AND PRINCETON, N.J., OCT. 10, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NAS...
Více zde
OPTHEA TO PARTICIPATE IN THE UBS VIRTUAL OPHTHALMOLOGY DAY 2024
30-09-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., SEPT. 30, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NAS...
Více zde
OPTHEA ANNOUNCES COMPLETION OF DRUG SUBSTANCE PPQ CAMPAIGN VALIDATING MANUFACTURING PROCESS OF SOZINIBERCEPT
18-09-2024
THREE CONSECUTIVE COMMERCIAL-SCALE BATCHES SUCCESSFULLY PRODUCED MAJOR MILESTONE FOR POTENTIAL BLA F...
Více zde
OPTHEA TO HAVE SIGNIFICANT PRESENCE AT THE 24ᵗʰ EURETINA CONGRESS AND EURETINA INNOVATION SPOTLIGHT
10-09-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., SEPT. 10, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NAS...
Více zde
OPTHEA ANNOUNCES EXECUTIVE LEADERSHIP CHANGES AND SENIOR HIRES
05-09-2024
DANIEL GEFFKEN APPOINTED CHIEF FINANCIAL OFFICER AD INTERIM MIKE CAMPBELL APPOINTED CHIEF COMMERCIAL...
Více zde
OPTHEA TO PARTICIPATE IN H.C. WAINWRIGHT 26TH GLOBAL INVESTMENT CONFERENCE AND CANTOR 2024 GLOBAL HEALTHCARE CONFERENCE
03-09-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., SEPT. 03, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NAS...
Více zde
OPTHEA REPORTS FULL-YEAR FINANCIAL RESULTS AND BUSINESS UPDATES
30-08-2024
COMPLETED PATIENT ENROLLMENT IN COAST AND SHORE PIVOTAL WET AMD TRIALS FINANCINGS EXTENDED CASH RUNW...
Více zde
OPTHEA TO PARTICIPATE IN THE H.C. WAINWRIGHT 4TH ANNUAL OPHTHALMOLOGY VIRTUAL CONFERENCE, AUGUST 15, 2024
08-08-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., AUG. 08, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NASD...
Více zde
OPTHEA WELCOMES INTERNATIONAL RETINA THOUGHT LEADERS TO JOIN ITS MEDICAL ADVISORY BOARD
17-07-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., JULY 17, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NASD...
Více zde
OPTHEA ANNOUNCES RESULTS OF THE A$55.9M (US$36.9M¹) RETAIL ENTITLEMENT OFFER
14-07-2024
NEW SHARES UNDER THE RETAIL ENTITLEMENT OFFER AND NEW OPTIONS UNDER THE PLACEMENT AND ENTITLEMENT OF...
Více zde
OPTHEA A$55.0M (US$36.9M¹) RETAIL ENTITLEMENT OFFER OPENS
18-06-2024
FULLY UNDERWRITTEN RETAIL ENTITLEMENT OFFER TO OPEN AT 9:00 AM (MELBOURNE TIME) ON 19 JUNE 2024 RE...
Více zde
OPTHEA SUCCESSFULLY COMPLETES PLACEMENT AND INSTITUTIONAL COMPONENT OF ENTITLEMENT OFFER RAISING A$171.5 MILLION (US$113.2M¹)
13-06-2024
FULLY UNDERWRITTEN RETAIL ENTITLEMENT OFFER TO RAISE A FURTHER APPROXIMATELY A$55.9M (US$36.9M 1 ) W...
Více zde
OPTHEA ANNOUNCES PLACEMENT AND PARTIALLY UNDERWRITTEN ENTITLEMENT OFFER TO RAISE UP TO APPROXIMATELY A$227.3 MILLION (US$150.0 MILLION¹)
11-06-2024
FINANCING EXTENDS OPTHEA'S CASH RUNWAY THROUGH PHASE 3 TOPLINE DATA READOUT FOR BOTH PIVOTAL TRIALS ...
Více zde
OPTHEA TO PRESENT AT CLINICAL TRIALS AT THE SUMMIT MEETING
03-06-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., JUNE 03, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NASD...
Více zde
OPTHEA COMPLETES ENROLLMENT IN PIVOTAL PHASE 3 CLINICAL PROGRAM WITH SOZINIBERCEPT IN WET AMD
28-05-2024
PHASE 3 PROGRAM ENROLLED 1,984 PATIENTS ACROSS COAST AND SHORE TRIALS TRIALS DESIGNED TO REPLICATE S...
Více zde
OPTHEA ANNOUNCES UPCOMING PRESENTATIONS AT THE RETINA WORLD CONGRESS 2024
01-05-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., MAY 01, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NASDA...
Více zde
OPTHEA TO PRESENT AT THE OIS RETINA INNOVATION SUMMIT AT ARVO
25-04-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., APRIL 25, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NAS...
Více zde
OPTHEA APPOINTS JOHN HAN, PHARMD, AS VP MEDICAL AFFAIRS
08-04-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., APRIL 08, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NAS...
Více zde
OPTHEA TO PARTICIPATE IN THE 23ʳᵈ ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
04-04-2024
MELBOURNE, AUSTRALIA AND PRINCETON, N.J., APRIL 04, 2024 (GLOBE NEWSWIRE) -- OPTHEA LIMITED (ASX/NAS...
Více zde
OPTHEA APPOINTS SUJAL SHAH TO THE BOARD OF DIRECTORS
03-04-2024
FORMER CYMABAY THERAPEUTICS CEO BRINGS EXTENSIVE LEADERSHIP EXPERIENCE TO HIS ROLE AS A NON-EXECUTIV...
Více zde
Dokumenty nejsou k dispozici
